Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Herr

Urology

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Urology|May 10, 2019
Preventable Cancer Deaths Associated with Bladder Preservation for Muscle Invasive Bladder CancerHarry Herr
Urology|September 3, 2022
WITHDRAWN: Neoadjuvant Chemotherapy and Bladder-Sparing Surgery for Muscle-Invasive Bladder Cancer: Ten-year OutcomesHarry Herr
Urology|May 16, 2025
Intensive Intravesical BCG-Induction in Patients With Asymptomatic BacteriuriaHarry Herr
Urology|May 2, 2017
Pursuing Novel Ideas-Confessions of Lost Opportunities!Harry Herr
Urology|May 19, 2019
EDITORIAL COMMENTHarry Herr
Urology|June 25, 2026
Low-Grade, Papillary Bladder Tumors A plea for in-office fulgurationHarry Herr
Urology|November 5, 2021
Cisplatin, Neoadjuvant Chemotherapy and Bladder CancerHarry Herr, Mark Soloway
Urology|October 26, 2018
Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic BacteriuriaHarry Herr, Machele Donat
Urology|August 7, 2016
Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?Harry Herr, Sherri Machele Donat
Urology|June 30, 2006
Complications after radical cystectomy: analysis of population-based dataBadrinath R Konety, Veerasathpurush Allareddy, Harry Herr
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Urology|May 10, 2019
Preventable Cancer Deaths Associated with Bladder Preservation for Muscle Invasive Bladder CancerHarry Herr
Urology|September 3, 2022
WITHDRAWN: Neoadjuvant Chemotherapy and Bladder-Sparing Surgery for Muscle-Invasive Bladder Cancer: Ten-year OutcomesHarry Herr
Urology|May 16, 2025
Intensive Intravesical BCG-Induction in Patients With Asymptomatic BacteriuriaHarry Herr
Urology|May 2, 2017
Pursuing Novel Ideas-Confessions of Lost Opportunities!Harry Herr
Urology|May 19, 2019
EDITORIAL COMMENTHarry Herr
Urology|June 25, 2026
Low-Grade, Papillary Bladder Tumors A plea for in-office fulgurationHarry Herr
Urology|November 5, 2021
Cisplatin, Neoadjuvant Chemotherapy and Bladder CancerHarry Herr, Mark Soloway
Urology|October 26, 2018
Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic BacteriuriaHarry Herr, Machele Donat
Urology|August 7, 2016
Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?Harry Herr, Sherri Machele Donat
Urology|June 30, 2006
Complications after radical cystectomy: analysis of population-based dataBadrinath R Konety, Veerasathpurush Allareddy, Harry Herr
Pageof 2